tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see NMRA full AI Analyst Report?

Neumora Therapeutics, Inc. (NMRA) Stock News & Sentiment

432 Followers
Neumora Ends Navacaprant After Phase 3 Trial Failure
Premium
Company Announcements
Neumora Ends Navacaprant After Phase 3 Trial Failure
5d ago
8K
NMRA
Neumora Shareholders Approve Directors, Auditor and Executive Pay
Premium
Company Announcements
Neumora Shareholders Approve Directors, Auditor and Executive Pay
22d ago
8K
NMRA
Analyst Reiterates Buy on Neumora, Maintaining $18 Price Target Ahead of Key KOASTAL-2/3 Depression Readouts
Premium
Ratings
Analyst Reiterates Buy on Neumora, Maintaining $18 Price Target Ahead of Key KOASTAL-2/3 Depression Readouts
24d ago
NMRA
Neumora’s NMRA-323511 Alzheimer’s Agitation Study Reaches Completion, Setting Up the Next Investor Catalyst
Premium
Company Announcements
Neumora’s NMRA-323511 Alzheimer’s Agitation Study Reaches Completion, Setting Up the Next Investor Catalyst
29d ago
NMRA
Neumora Therapeutics Securities Lawsuit Enters New Procedural Phase as Plaintiffs Prepare New Complaint
Premium
Class Action
Neumora Therapeutics Securities Lawsuit Enters New Procedural Phase as Plaintiffs Prepare New Complaint
1M ago
NMRA
Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target
Premium
Ratings
Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target
1M ago
NMRA
Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside
Premium
Ratings
Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside
1M ago
NMRA
More NMRA News >

NMRA News on the Web

Clear Street says Neumora failed trial does not impact LB Pharmaceuticals LB-102
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neumora Therapeutics, Inc. (NMRA) and Amgen (AMGN)
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Neumora Ends Navacaprant After Phase 3 Trial Failure
TipRanks News
Neutral
Neumora Therapeutics announces KOASTAL studies miss primary endpoint
TipRanks News
Bearish
Neumora Shareholders Approve Directors, Auditor and Executive Pay
TipRanks News
Bearish
Analysts Conflicted on These Healthcare Names: CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therapeutics, Inc. (NMRA)
TipRanks News
Bearish
Analyst Reiterates Buy on Neumora, Maintaining $18 Price Target Ahead of Key KOASTAL-2/3 Depression Readouts
TipRanks News
Bullish

News Score - Last 7 Days

Very Negative
NMRA
Sector Average
Media Buzz
This Week10 articles
Weekly Average1.5 articles
News Sentiment
This Week13%
Sector Average90%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NMRA’s Media Buzz Sentiment?
10 articles about NMRA were published this week. In an average week, 1.5 articles are published.
    What is NMRA’s weekly average amount of articles?
    In an average week, 1.5 articles about NMRA are published.
      What is NMRA’s News Sentiment?
      13% of articles about NMRA were positive this week, compared to its sector average of 90%.
        Healthcare Stocks that are Trending in the News
        QUREuniQure
        RYTMRhythm Pharmaceuticals
        HITIHigh Tide
        SLPSimulations Plus
        NTLAIntellia Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week